Back to Selection     Print       Date : 30 Jun 2025
Fund Summary
Tata India Pharma & HealthCare Fund Reg Plan (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 28-Dec-2015
Corpus(Cr.) 1282.0 Latest NAV 31.3901 As on 30-07-2025
Equity(%) 92.31 52 Week High 32.0131
Debt(%) 7.69 52 Week Low 26.5729
Others(%) 0.0 Exit Load -
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.11
Scheme Benchmark NIFTY Pharma TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Rajat Srivastava
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 37.08%
Top 10 Holdings 60.52%
Top 25 Holdings 88.82%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 57.69
Healthcare 29.11
Cash 7.69
Miscellaneous 2.7
Fertilisers 1.17
Retail 0.84
Software & Services 0.52
Chemicals 0.28
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.54
PE Ratio 29.99
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 11.17
CASH / NET CURRENT ASSET 7.38
Apollo Hospitals Enterprise Limited 7.19
Cipla Limited 5.76
DIVI LABORATORIES LTD. 5.58
Aurobindo Pharma Limited 5.44
Fortis Health Care Ltd 5.30
Lupin Limited 4.58
Aster DM Healthcare Limited 4.45
Wockhardt Limited 3.67
Alkem Laboratories Limited 2.90
Healthcare Global Enterprises Limited 2.86
METROPOLIS HEALTHCARE LIMITED 2.42
Dr Reddys Laboratories Limited 2.12
Dr Lal Path Labs Ltd 1.91
Ajanta Pharma Limited 1.90
Torrent Pharmaceuticals Limited 1.89
FDC Limited 1.79
Medi Assist Healthcare Services Limited 1.74
Krishna Inst of Medical Sciences Ltd. 1.72
Indoco Remedies Limited 1.65
IPCA Laboratories Limited 1.54
Dr Agarwals Health Care Limited 1.44
EQ- JUPITER LIFE LINE HOSPITALS LTD 1.24
Akums Drugs & Pharmaceuticals Ltd 1.18

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
3.95% 6.95% 7.58% 9.88%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
-2.43% 2.80% 7.76% 1.27%
 
Scheme Benchmark [NSE - Nifty Pharma]
4.70% 5.98% 7.72% 7.12%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
25.88% 24.31% 21.03% 0.00%
 
 
13.82% 14.44% 18.90% 12.79%
 
 
24.07% 21.73% 16.46% 6.69%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Tata India Pharma & HealthCare Fund Reg Plan (G) 15.93% 0.0000 0.0000% 0.0000 0.0000
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Tata India Pharma & HealthCare Fund Reg Plan (G) 0.0000% 0.0000 0.0000 0.0000 0.0000
 
Back to Selection